Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
- Conditions
- Chronic Kidney Failure
- Interventions
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 1000
- Registration Number
- NCT00844662
- Locations
- 🇺🇸
Arkansas Nephrology Services Ltd, Hot Springs, Arkansas, United States
🇺🇸National Institute of Clinical Research, Bakersfield, California, United States
🇺🇸Renal Medical Associates, Lynwood, California, United States
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
- Conditions
- Chronic Kidney Failure
- Interventions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 657
- Registration Number
- NCT00841126
- Locations
- 🇺🇸
Nephrology Associates PC, Birmingham, Alabama, United States
🇺🇸Arizona Kidney Disease and Hypertension Center, Phoenix, Arizona, United States
🇺🇸Southwest Kidney Institute, Tempe, Arizona, United States
Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 64
- Registration Number
- NCT00436683
- Locations
- 🇬🇧
Department of Renal Medicine, Derby City General Hospital, Uttoxeter Road, Derby, Derbyshire, United Kingdom
🇬🇧Queens Dialysis Unit, Rom Valley Way, Romford, Essex, United Kingdom
🇬🇧Renal Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom
An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 44
- Registration Number
- NCT00358722
- Locations
- 🇺🇸
1614 West 42nd Street, Pine Bluff, Arkansas, United States
🇺🇸US Renal Care, Stuttgart, Arkansas, United States
🇺🇸Davita Dialysis Center, Charlotte, North Carolina, United States
Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
- First Posted Date
- 2006-04-25
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 111
- Registration Number
- NCT00317694
- Locations
- 🇺🇸
1614 West 42nd Street, Pine Bluff, Arkansas, United States
🇺🇸US Renal Care, Stuttgart, Arkansas, United States
🇺🇸Davita Dialysis Center, Charlotte, North Carolina, United States